×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RDY – dr. reddy's laboratories ltd (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RDY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
11:18 am
rdy
Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments [Yahoo! Finance]
Low
Report
Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments [Yahoo! Finance]
3/20
01:30 pm
rdy
Ozempic copies for $14 as the generic GLP-1 era starts in India [Los Angeles Times (CA)]
Low
Report
Ozempic copies for $14 as the generic GLP-1 era starts in India [Los Angeles Times (CA)]
3/17
03:48 am
rdy
India's Zydus, Lupin sign deal to co-market Semaglutide injections [Yahoo! Finance]
Low
Report
India's Zydus, Lupin sign deal to co-market Semaglutide injections [Yahoo! Finance]
3/16
12:25 pm
rdy
Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk [MSNBC.com]
Low
Report
Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk [MSNBC.com]
3/16
09:39 am
rdy
India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs [Yahoo! Finance]
Low
Report
India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs [Yahoo! Finance]
3/16
08:32 am
rdy
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results [Yahoo! Finance]
Low
Report
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results [Yahoo! Finance]
3/16
08:04 am
rdy
Ticagrelor Market Size to Reach USD 3.60 Billion by 2035, Fueled by Rising Cardiovascular Disease Burden and Growing Adoption of Advanced Antiplatelet Therapies – SNS Insider [Yahoo! Finance]
Low
Report
Ticagrelor Market Size to Reach USD 3.60 Billion by 2035, Fueled by Rising Cardiovascular Disease Burden and Growing Adoption of Advanced Antiplatelet Therapies – SNS Insider [Yahoo! Finance]
3/16
07:21 am
rdy
Prolonged Strait of Hormuz standoff will close in on America's generic drug prescriptions [CNBC]
Low
Report
Prolonged Strait of Hormuz standoff will close in on America's generic drug prescriptions [CNBC]
Date
Time
Symbol
Company Name
Action
%Chg
1/22/2026
04:05 pm
rdy
dr. reddy's laboratories ltd
BEAT
Report
-0.2%
dr. reddy's laboratories ltd
1/21/2026
04:06 pm
rdy
dr. reddy's laboratories ltd
BEAT
Report
3.2%
dr. reddy's laboratories ltd
1/21/2026
07:06 am
rdy
dr. reddy's laboratories ltd
BEAT
Report
3.3%
dr. reddy's laboratories ltd
7/24/2025
04:01 pm
rdy
dr. reddy's laboratories ltd
BEAT
Report
0.4%
dr. reddy's laboratories ltd
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
01:05 pm
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: AGHANIAN PATRICK RUDOLF
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: AGHANIAN PATRICK RUDOLF
4/1
12:43 pm
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: KALAWADIA MILAN KANTILAL
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: KALAWADIA MILAN KANTILAL
4/1
11:53 am
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: MOTUPALLI VENKATA RAMANA
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: MOTUPALLI VENKATA RAMANA
4/1
11:29 am
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: Israeli Erez
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: Israeli Erez
4/1
11:28 am
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: VENKATESH KRISHNA
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: VENKATESH KRISHNA
4/1
11:27 am
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: KULKARNI SUSHRUT
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: KULKARNI SUSHRUT
4/1
09:40 am
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: BHETHANABOTTLA SRINIVASA PHANIMITRA
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: BHETHANABOTTLA SRINIVASA PHANIMITRA
4/1
09:40 am
rdy
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: MANNAM VENKATA NARASIMHAM
Low
Report
Form 3 DR REDDYS LABORATORIES For: Dec 18 Filed by: MANNAM VENKATA NARASIMHAM
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Dr.Reddy's Laboratories Ltd (NYSE: RDY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.
6.2%
1/27 Form 6-K DR REDDYS LABORATORIES For: Jan 27 5.3%
4/9 Form SC 13G/A DR REDDYS LABORATORIES Filed by: BlackRock Inc. 4.8%
3/20 Dr. Reddy's launches pyrimethamine tablets in U.S. [Seeking Alpha] 3.9%
3/17 Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market 3.0%
10/23 Dr. Reddy’s Confirms Its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market 2.8%
7/29 Dr. Reddy's Laboratories Limited 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 2.8%
9/11 Hazmat situation reported at Dr. Reddy's New York facility [Seeking Alpha] 2.8%
5/20 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A 2.7%
9/9 Form SC 13G DR REDDYS LABORATORIES Filed by: COMMONWEALTH BANK OF AUSTRALIA 2.4%
1/27 Form 6-K DR REDDYS LABORATORIES For: Jan 27 5.3%
4/9 Form SC 13G/A DR REDDYS LABORATORIES Filed by: BlackRock Inc. 4.8%
3/20 Dr. Reddy's launches pyrimethamine tablets in U.S. [Seeking Alpha] 3.9%
3/17 Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market 3.0%
10/23 Dr. Reddy’s Confirms Its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market 2.8%
7/29 Dr. Reddy's Laboratories Limited 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 2.8%
9/11 Hazmat situation reported at Dr. Reddy's New York facility [Seeking Alpha] 2.8%
5/20 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A 2.7%
9/9 Form SC 13G DR REDDYS LABORATORIES Filed by: COMMONWEALTH BANK OF AUSTRALIA 2.4%
TOP News Decliners
3/12
Form 6-K DR REDDYS LABORATORIES For: Mar 12
-6.6%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -6.0%
3/16 Form 6-K DR REDDYS LABORATORIES For: Mar 14 -4.6%
7/29 Dr. Reddy’s Q1 FY20 Financial Results -3.3%
7/29 Q1/2020 6/30/2019 EPS 39.910 ZacksConsensus N/A ActVsEst N/A - N/A -2.9%
7/23 Form 6-K DR REDDYS LABORATORIES For: Jul 23 -2.5%
2/27 Dr. Reddy's Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market -2.3%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -1.9%
10/23 Dr. Reddy's is recalling some products used to treat heartburn [CNN] -1.8%
11/22 Dr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market -1.7%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -6.0%
3/16 Form 6-K DR REDDYS LABORATORIES For: Mar 14 -4.6%
7/29 Dr. Reddy’s Q1 FY20 Financial Results -3.3%
7/29 Q1/2020 6/30/2019 EPS 39.910 ZacksConsensus N/A ActVsEst N/A - N/A -2.9%
7/23 Form 6-K DR REDDYS LABORATORIES For: Jul 23 -2.5%
2/27 Dr. Reddy's Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market -2.3%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -1.9%
10/23 Dr. Reddy's is recalling some products used to treat heartburn [CNN] -1.8%
11/22 Dr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: